Mersana Therapeutics

2 followers

Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.

Industries

Employees

51-200

Links


Org chart

Martin Huber
President & Chief Executive Officer
Collapse
Brian C. Deschuytner
Chief Operating Officer & Chief Financial Officer
Timothy B. Lowinger
Chief Science & Technology Officer
Mohan Bala
SVP & Chief Development Officer
Lei Zhu
Executive Director
Caryn Crasnick-Maloney
Vice President, Human Resources
Katharin Blackerby-Burke
Executive Director, Medical Writing And Regulatory Strategy
Richard Fredericks
Senior Director - Regulatory, Quality & Clinical Solutions (rqcs)
Brigitte Eichner
Executive Director, Corporate Counsel

Board & advisors

David Mott
Chairman
Andrew Hack
Director
Christoph Lengauer
Scientific Advisor
Howard A. Skip Burris III
Scientific Advisor
Peter A. Kiener
Scientific Advisor
K. Dane Wittrup
Scientific Advisor